---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-108935"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2026-09-18T20:05:35+00:00"
generated_at: "2026-09-18T20:07:21.314564+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TELA Bio faces Nasdaq delisting over bid price; plans hearing and reverse split

## Summary
- Nasdaq notified TELA Bio on 9/15/26 it is subject to delisting for failing $1.00 minimum bid price rule.
- Company intends to request a Nasdaq Hearings Panel hearing, which will stay any suspension pending outcome.
- Filed proxy for reverse stock split (1-for-5 to 1-for-15) to regain bid price compliance; special meeting 10/8/26.
- No assurance stockholders approve reverse split; delisting risk persists if not approved or price not sustained.

## SEC filing metadata
- accession: 0001104659-26-108935
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2026-09-18T20:05:35+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465926108935/0001104659-26-108935-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465926108935/tm2625586d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-108935
- JSON: https://secwatch.observer/filing/0001104659-26-108935.json
- Plain text: https://secwatch.observer/filing/0001104659-26-108935.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.